Section Arrow
Quote
RCEL.NASDAQ
- Avita Medical
Quotes are at least 15-min delayed:2025/01/21 05:37 EST
Last
 8.65
+0.11 (+1.29%)
Day High 
8.78 
Prev. Close
8.54 
1-M High
14.16 
Volume 
178.98K 
Bid
8.5
Ask
11
Day Low
8.55 
Open
8.7 
1-M Low
8.51 
Market Cap 
223.90M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 10.7 
20-SMA 11.58 
50-SMA 12.23 
52-W High 18.93 
52-W Low 7.51 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.23/-1.57
Enterprise Value
265.41M
Balance Sheet
Book Value Per Share
0.47
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
50.14M
Operating Revenue Per Share
1.56
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed：2025/01/21 05:37 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.